Cencora (COR) vs ZeroStack (ZSTK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Cencora (COR) has outperformed ZeroStack (ZSTK) over the past year, gaining 2.8% versus a loss of 75.9%. Over five years, COR leads with a +164.7% price change compared with -99.9% for ZSTK. Cencora is the larger company by market cap ($61.32 billion vs $101.1 million), about 606.3 times the size.
Cencora pays a dividend yielding 0.73%, while ZeroStack does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COR | ZSTK |
|---|---|---|
| Share price | $321.35 | $4.64 |
| Market cap | $61.32B | $101.14M |
| 1-day change | +1.29% | -2.73% |
| YTD return | -6.07% | -25.88% |
| 1-year return | +2.77% | -75.87% |
| 5-year return | +164.68% | -99.88% |
| P/E ratio (TTM) | 23.86 | — |
| Forward P/E | 16.23 | — |
| EPS (TTM) | $13.47 | $-43.81 |
| Dividend yield | 0.73% | 0.00% |
| Annual dividend | $2.35 | $0.00 |
| Revenue (latest FY) | $321.33B | — |
| Revenue growth (YoY) | +9.31% | — |
| Net income (latest FY) | $1.55B | — |
| Gross margin | 3.57% | — |
| Operating margin | 0.82% | — |
| Net margin | 0.48% | — |
| 52-week high | $377.54 | $20.45 |
| 52-week low | $244.82 | $1.32 |
| Distance from 52-week high | -14.88% | -77.31% |
| Analyst consensus | buy | none |
| Avg. price target upside | +14.91% | +137.07% |
| Average volume | 1.32M | 486.97K |
| Shares outstanding | 190.83M | 21.80M |
| Employees | 47,000 | 21 |
| Sector | Health Care | Financial Services |
| Industry | Other Pharmaceuticals | Asset Management |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cencora is about 606.3 times larger than ZeroStack by market value ($61.32B vs $101.14M).
- COR has outperformed ZSTK by 78.6 percentage points over the past year.
- The two companies sit in different sectors: Cencora in Health Care and ZeroStack in Financial Services.
About Cencora
COR stock →Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally.
Health Care · Other Pharmaceuticals · 47,000 employees
About ZeroStack
ZSTK stock →ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments.
Financial Services · Asset Management · 21 employees
COR vs ZSTK FAQ
Which is bigger, Cencora or ZeroStack?
Cencora (COR) is larger, with a market capitalization of $61.32B compared with $101.14M for ZeroStack (ZSTK).
Which stock has performed better over the past year, COR or ZSTK?
COR returned +2.77% over the past 12 months, compared with -75.87% for ZSTK (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Cencora or ZeroStack?
Cencora pays a dividend yielding 0.73%, while ZeroStack does not currently pay a regular dividend.
Are Cencora and ZeroStack in the same industry?
No. Cencora is in the Health Care sector, while ZeroStack is in Financial Services.